Literature DB >> 17594938

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

Evemie Schutyser1, Yingjun Su, Yingchun Yu, Mieke Gouwy, Snjezana Zaja-Milatovic, Jo Van Damme, Ann Richmond.   

Abstract

The influence of environmental factors (cytokines, matrix components, serum factors and O(2) level) on expression of receptors for angiogenic versus angiostatic CXC chemokines in human microvascular endothelial cells has not been extensively investigated. Our semi-quantitative RT-PCR analysis demonstrated that TNF-alpha and IFN-gamma repressed CXCR4 mRNA levels in immortalized human microvascular endothelial HMEC-1 cells after 4 h, whereas only TNF-alpha displayed inhibitory activity in primary human microvascular endothelial cells (HMVEC). CXCR4 mRNA expression was not affected by VEGF, GM-CSF, IL-1beta or various basal membrane matrix components, but was significantly up-regulated after serum starvation and/or hypoxic treatment of the microvascular endothelial cells. The alternative CXCL12 receptor, CXCR7/RDC1, was also up-regulated by hypoxia in HMEC-1 cells, although less consistently than CXCR4. Furthermore, hypoxia and serum starvation were required for cell surface display of CXCR4 and CXCL12 induction of ERK activation in HMEC-1 cells. In contrast, CXCR2 and CXCR3 mRNA levels remained, respectively, low and undetectable under all the conditions tested, and surface expression of CXCR2, CXCR3 and CXCR7 on the HMEC- 1 cells could not be demonstrated by FACS. In the human SK-MEL-5 melanoma cell line, CXCR4 mRNA expression was also increased under hypoxic conditions, whereas CXCR2 mRNA levels remained low and levels of CXCR3 and CXCR7 were undetectable. However, immunohistochemical staining of human metastatic melanoma sections demonstrated that CXCR2, CXCR3, CXCR4 and CXCR7 are expressed on tumor cells and, to a lesser extent, on endothelial cells. These results demonstrate that the tumor microenvironment regulates chemokine receptor expression through both cytokine and oxygen levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594938      PMCID: PMC2665278          DOI: 10.1684/ecn.2007.0087

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  59 in total

Review 1.  Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research.

Authors:  D Bouïs; G A Hospers; C Meijer; G Molema; N H Mulder
Journal:  Angiogenesis       Date:  2001       Impact factor: 9.596

2.  Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.

Authors:  M M Robledo; R A Bartolome; N Longo; J M Rodríguez-Frade; M Mellado; I Longo; G N van Muijen; P Sánchez-Mateos; J Teixidó
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

3.  A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.

Authors:  K Soejima; B J Rollins
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

4.  Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.

Authors:  Lynn J Poole; Yanxing Yu; Peter S Kim; Qi-Zhi Zheng; Jonathan Pevsner; Gary S Hayward
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis.

Authors:  Aihua Li; Seema Dubey; Michelle L Varney; Bhavana J Dave; Rakesh K Singh
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

6.  Regulation of chemokine receptor expression in human microglia and astrocytes.

Authors:  Geraldine Flynn; Seema Maru; Jane Loughlin; Ignacio A Romero; David Male
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

7.  Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Authors:  Ombretta Salvucci; Lei Yao; Sabrina Villalba; Agatha Sajewicz; Stefania Pittaluga; Giovanna Tosato
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells.

Authors:  G Spinetti; G Camarda; G Bernardini; S Romano Di Peppe; M C Capogrossi; M Napolitano
Journal:  Biochem Biophys Res Commun       Date:  2001-11-23       Impact factor: 3.575

9.  Differential adhesion of polymorphous neutrophilic granulocytes to macro- and microvascular endothelial cells under flow conditions.

Authors:  M Otto; F Bittinger; J Kriegsmann; C J Kirkpatrick
Journal:  Pathobiology       Date:  2001       Impact factor: 4.342

10.  Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.

Authors:  Jan Heidemann; Hitoshi Ogawa; Michael B Dwinell; Parvaneh Rafiee; Christian Maaser; Henning R Gockel; Mary F Otterson; David M Ota; Norbert Lugering; Wolfram Domschke; David G Binion
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

View more
  37 in total

Review 1.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

2.  Cell-specific translational profiling in acute kidney injury.

Authors:  Jing Liu; A Michaela Krautzberger; Shannan H Sui; Oliver M Hofmann; Ying Chen; Manfred Baetscher; Ivica Grgic; Sanjeev Kumar; Benjamin D Humphreys; Benjamin Humphreys; Winston A Hide; Andrew P McMahon
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 3.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 4.  The unique structural and functional features of CXCL12.

Authors:  Rik Janssens; Sofie Struyf; Paul Proost
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

Review 5.  CXC chemokines in cancer angiogenesis and metastases.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

6.  Differential expression of RDC1/CXCR7 in the human placenta.

Authors:  Vishwas Tripathi; Romsha Verma; Amit Dinda; Neena Malhotra; Jagdeep Kaur; Kalpana Luthra
Journal:  J Clin Immunol       Date:  2008-10-28       Impact factor: 8.317

Review 7.  The role of stromal-derived factor-1--CXCR7 axis in development and cancer.

Authors:  Radoslaw B Maksym; Maciej Tarnowski; Katarzyna Grymula; Joanna Tarnowska; Marcin Wysoczynski; Riu Liu; Boguslaw Czerny; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

8.  CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.

Authors:  Gabriele S V Campanella; Richard A Colvin; Andrew D Luster
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

9.  Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.

Authors:  Zhen Liu; Da-Xin Sun; Xu-Yong Teng; Wei-Xue Xu; Xiang-Peng Meng; Bao-Sheng Wang
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

10.  CXCR7 functions as a scavenger for CXCL12 and CXCL11.

Authors:  Ulrike Naumann; Elisabetta Cameroni; Monika Pruenster; Harsha Mahabaleshwar; Erez Raz; Hans-Günter Zerwes; Antal Rot; Marcus Thelen
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.